Factors associated with utilization of neoadjuvant chemotherapy in charlson comorbidity zero non-metastatic muscle-invasive bladder cancer patients

BACKGROUND: Guideline-based best practice treatment for muscle invasive bladder cancer (MIBC) involves neoadjuvant chemotherapy followed by radical cystectomy (NACRC). Prior studies have shown that a minority of patients receive NACRC and older age and renal function are drivers of non-receipt of NA...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int Braz J Urol
Autors principals: Au, Daniel, Lee, Eugene K., Popoola, Taiye O., Parker, William P., Onge, Jarron M. Saint, Ellis, Shellie D.
Format: Artigo
Idioma:Inglês
Publicat: Sociedade Brasileira de Urologia 2021
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8321501/
https://ncbi.nlm.nih.gov/pubmed/33848073
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1590/S1677-5538.IBJU.2020.0594
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars